Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy DOI Creative Commons
Pataje G.S. Prasanna, Deborah E. Citrin,

Jeffrey Hildesheim

et al.

JNCI Journal of the National Cancer Institute, Journal Year: 2021, Volume and Issue: 113(10), P. 1285 - 1298

Published: March 31, 2021

Cellular senescence is an essential tumor suppressive mechanism that prevents the propagation of oncogenically activated, genetically unstable, and/or damaged cells. Induction cell also one underlying mechanisms by which cancer therapies exert antitumor activity. However, increasing body evidence from preclinical studies demonstrates radiation and chemotherapy cause accumulation senescent cells (SnCs) both in normal tissue. SnCs tumors can, paradoxically, promote relapse, metastasis, resistance to therapy, part, through expression senescence-associated secretory phenotype. In addition, tissue can contribute certain radiation- chemotherapy-induced side effects. Because its multiple roles, cellular could serve as important target fight against cancer. This commentary provides a summary discussion at National Cancer Institute Workshop on Radiation, Senescence, (August 10-11, 2020, Institute, Bethesda, MD) regarding current status research, heterogeneity therapy-induced senescence, senotherapeutics molecular biomarkers, concept "one-two punch" therapy (consisting therapeutics induce followed selective clearance SnCs), integration with personalized adaptive therapy. It identifies key knowledge gaps outlines future directions this emerging field improve treatment outcomes for patients.

Language: Английский

Hallmarks of Cancer: New Dimensions DOI Open Access
Douglas Hanahan

Cancer Discovery, Journal Year: 2022, Volume and Issue: 12(1), P. 31 - 46

Published: Jan. 1, 2022

The hallmarks of cancer conceptualization is a heuristic tool for distilling the vast complexity phenotypes and genotypes into provisional set underlying principles. As knowledge mechanisms has progressed, other facets disease have emerged as potential refinements. Herein, prospect raised that phenotypic plasticity disrupted differentiation discrete hallmark capability, nonmutational epigenetic reprogramming polymorphic microbiomes both constitute distinctive enabling characteristics facilitate acquisition capabilities. Additionally, senescent cells, varying origins, may be added to roster functionally important cell types in tumor microenvironment. SIGNIFICANCE: Cancer daunting breadth scope its diversity, spanning genetics, tissue biology, pathology, response therapy. Ever more powerful experimental computational tools technologies are providing an avalanche "big data" about myriad manifestations diseases encompasses. integrative concept embodied helping distill this increasingly logical science, new dimensions presented perspective add value endeavor, fully understand development malignant progression, apply medicine.

Language: Английский

Citations

3308

Hallmarks of aging: An expanding universe DOI Creative Commons
Carlos López‐Otín, Marı́a A. Blasco, Linda Partridge

et al.

Cell, Journal Year: 2023, Volume and Issue: 186(2), P. 243 - 278

Published: Jan. 1, 2023

Language: Английский

Citations

2784

Cellular senescence in ageing: from mechanisms to therapeutic opportunities DOI
Raffaella Di Micco, Valery Krizhanovsky, Darren J. Baker

et al.

Nature Reviews Molecular Cell Biology, Journal Year: 2020, Volume and Issue: 22(2), P. 75 - 95

Published: Dec. 16, 2020

Language: Английский

Citations

1479

Fibrosis: from mechanisms to medicines DOI
Neil C. Henderson, Florian Rieder, Thomas A. Wynn

et al.

Nature, Journal Year: 2020, Volume and Issue: 587(7835), P. 555 - 566

Published: Nov. 25, 2020

Language: Английский

Citations

1229

Senescence and the SASP: many therapeutic avenues DOI Open Access
Jodie Birch, Jesús Gil

Genes & Development, Journal Year: 2020, Volume and Issue: 34(23-24), P. 1565 - 1576

Published: Dec. 1, 2020

Cellular senescence is a stress response that elicits permanent cell cycle arrest and triggers profound phenotypic changes such as the production of bioactive secretome, referred to senescence-associated secretory phenotype (SASP). Acute induction protects against cancer limits fibrosis, but lingering senescent cells drive age-related disorders. Thus, targeting delay aging limit dysfunction, known “senotherapy,” gaining momentum. While drugs selectively kill cells, termed “senolytics” are major focus, SASP-centered approaches emerging alternatives target diseases. Here, we summarize regulation functions SASP highlight therapeutic potential modulation complimentary or an alternative current senolytic approaches.

Language: Английский

Citations

786

Atherosclerosis: Recent developments DOI Creative Commons
Johan Björkegren, Aldons J. Lusis

Cell, Journal Year: 2022, Volume and Issue: 185(10), P. 1630 - 1645

Published: May 1, 2022

Atherosclerosis is an inflammatory disease of the large arteries that major cause cardiovascular (CVD) and stroke. Here, we review current understanding molecular, cellular, genetic, environmental contributions to atherosclerosis, from both individual pathway systems perspectives. We place emphasis on recent developments, some which have yielded unexpected biology, including previously unknown heterogeneity smooth muscle cells in atherosclerotic lesions, roles for senescence clonal hematopoiesis, links gut microbiome.

Language: Английский

Citations

655

Cellular senescence and senolytics: the path to the clinic DOI Open Access
Selim Chaib, Tamar Tchkonia, James L. Kirkland

et al.

Nature Medicine, Journal Year: 2022, Volume and Issue: 28(8), P. 1556 - 1568

Published: Aug. 1, 2022

Language: Английский

Citations

627

Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy DOI Open Access
Emma Morris, Sattva S. Neelapu, Theodoros Giavridis

et al.

Nature reviews. Immunology, Journal Year: 2021, Volume and Issue: 22(2), P. 85 - 96

Published: May 17, 2021

Language: Английский

Citations

616

Cellular senescence: the good, the bad and the unknown DOI Open Access
Weijun Huang, LaTonya J. Hickson, Alfonso Eirin

et al.

Nature Reviews Nephrology, Journal Year: 2022, Volume and Issue: 18(10), P. 611 - 627

Published: Aug. 3, 2022

Language: Английский

Citations

614

Exploiting senescence for the treatment of cancer DOI Open Access
Liqin Wang, Lina Lankhorst, René Bernards

et al.

Nature reviews. Cancer, Journal Year: 2022, Volume and Issue: 22(6), P. 340 - 355

Published: March 3, 2022

Language: Английский

Citations

518